Michael Barbella

2 days ago | odtmag.com | Michael Barbella |Sam Brusco |Rachel Klemovitch

Medacta Group SA is showcasing its expanded sports medicine portfolio next week at the 15th Biennial International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine (ISAKOS) Congress in Munich, Germany (June 8-11). Medacta bolstered its sports medicine offerings upon acquiring Parcus Medical in March from Anika Therapeutics. Among the expanded solutions being highlighted at the show (booth 03A) is the X-Twist anchor platform and Draw Tight all-suture anchor fixation systems.

3 days ago | odtmag.com | Michael Barbella |Sam Brusco

THINK Surgical Inc. has welcomed a new member to its C-Suite, hiring robotics commercialization and operations expert Chris Marrus as executive vice president. As a senior member of THINK Surgical’s executive leadership team, Marrus will help President/CEO Stuart Simpson coordinate and strengthen all areas of the business, including key initiatives in financing, product development, and operational growth planning.

5 days ago | odtmag.com | Sam Brusco |Michael Barbella |Rachel Klemovitch

Johnson & Johnson MedTech has launched its Kincise 2 surgical automated system, a next-gen automated power tool for primary and revision hip, and revision knee replacement procedures. The Kincise 2 automated surgical impactor was engineered to boost surgical efficiency, provide control, and reduce physical burden on surgeons compared to manual impaction, the company said.

6 days ago | mpo-mag.com | Michael Barbella

Qosina, through a new strategic partnership with Sealed Air is introducing NEXCEL BIO1250, a robust, co-extruded bioprocessing bag film, to its bioprocessing solutions lineup. As an official distributor, Qosina now offers NEXCEL BIO1250 bag chamber film in a 138-square-meter roll format. Designed for manufacturing single-use bioprocessing bags, this PE-based film delivers exceptional durability, chemical resistance and performance at ultra-low temperatures (down to -80°C).

6 days ago | mpo-mag.com | Michael Barbella

DNV has been recognized by the European Commission as a notified body for certifying devices under the European Union’s In Vitro Diagnostic Regulation (IVDR). The designation increases capacity for certifying in-vitro diagnostic devices and providing EU market access. DNV offers device manufacturers a fully digital process for faster, more transparent device certification. In-vitro diagnostics (IVDs) are tests used to determine a patient’s health status.